Skip to content
Join our community and subscribe to our free weekly newsletter
Subscribe
Toggle Navigation
Latest News
Articles
Live Talks
Trials Update
Prevention & Risk Factors
Science-Backed Dementia Prevention
Alzheimer’s Genetics & Risk Factors
Menopause
Long COVID
Dementias
Alzheimer’s Disease
Vascular Dementia
Frontotemporal Dementia (FTD)
Lewy Body Dementia
Traumatic Brain Injury & CTE
Brain Disorders
Mild Cognitive Impairment (MCI)
Parkinson’s Disease
Getting Diagnosed
Diagnosis
Journey to Diagnosis
Genetic Testing
Alzheimer’s Biomarkers
Diversity and Dementia
Caregivers
Caregiver Voices
Learning Guides
Search for:
Search for:
Simon Spichak, MSc
Long COVID 101: Patients and Doctors Explain the Condition
How Sex Hormones, Chromosomes, and Menopause Affect Women’s Brain Health
Research Into a COVID-Alzheimer’s Link Continues
Defying Genetic Destiny: The Man Whose Brain Resisted Early-Onset Alzheimer’s
Australia Is Latest Country to Say ‘No’ to Leqembi
Could a Chronic Gut Infection Trigger Alzheimer’s?
Do Statins Cause Dementia? Here’s What the Science Actually Says
Rising Microplastic Levels in the Brain: A Growing Concern
High-tech Headsets to Combat Alzheimer’s
TRIALS UPDATE: The Latest Alzheimer’s Clinical Trial News (2025.01)
‘Unsettling:’ Federal DEI Ban a ‘Step Backward’ for Alzheimer’s Trials
‘Mission Critical’: Why the FDA Approved an Alzheimer’s Drug Update During Comms Freeze
Feeling Lonely Linked to Higher Risk of Dementia in Older Adults
Leqembi Vs. Kisunla: An Alzheimer’s Drug Point-by-Point Comparison
NIH Activities Grind to Halt Under Trump Comms Freeze
Previous
9
10
11
Next
Page load link
Go to Top